Ads
related to: cancer, pharmaceuticals- Dosing and Administration
Explore the Convenient Dosing
Schedule for MAVENCLAD®.
- How It May Work
Discover the Proposed Mechanism of
Action of MAVENCLAD®.
- Treatment Efficacy
Learn More About Efficacy & Safety
Data for MAVENCLAD®.
- Service Request Form
Download to Get Started
With MAVENCLAD® Today.
- Prescribing Info
Review Prescribing Information
For MAVENCLAD®.
- Safety Profile
Discover Info About the Safety &
Tolerability Profile of MAVENCLAD®.
- Dosing and Administration
Search results
AstraZeneca’s Lung, Breast Cancer Drugs Markedly Slow Disease
Bloomberg· 6 hours agoAstraZeneca Plc’s lung and breast cancer drugs significantly slowed the spread of disease in two...
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030
Motley Fool via Yahoo Finance· 5 hours agoLilly's market cap is $767 billion, while Novo Nordisk's is $447 billion. Does one of these ...
GSK blood cancer drug nearly halves risk of death in late-stage trial
KFGO· 6 hours agoBy Pratik Jain (Reuters) - GSK's multiple myeloma drug Blenrep nearly halved the risk of disease...
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 10 hours agoAstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live...
FDA prioritizes review of Jazz Pharmaceuticals' new cancer therapy By Investing.com
Investing.com· 4 days agoJazz Pharmaceuticals (NASDAQ:JAZZ) announced that the U.S. Food and Drug Administration (FDA) has...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow... HER2-Positive Biliary Tract ...
KOLR - KSFX Ozarks· 1 day agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase 2b HERIZON-BTC ...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 10 hours agoThe trial results are a step forward for antibody-drug conjugates, which Enhertu makers AstraZeneca...
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer - Jazz ...
Benzinga· 4 days agoTarget Action (PDUFA) Date set for November 29, 2024 If approved, zanidatamab will be the first HER2-targeted treatment specifically indicated for patients with HER2+ locally advanced or metastatic biliary tract
Thousands of NHS patients to trial new personalised cancer vaccine in ‘landmark moment’
The Independent via Yahoo News· 2 days agoThe scheme will work with a range of pharmaceutical companies and could expand to include patients...
Phio Pharmaceuticals advances to next dose in cancer trial By Investing.com
Investing.com· 5 days agoPhio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company specializing in gene silencing...
Ads
related to: cancer, pharmaceuticals
